Back to News
Market Impact: 0.1
HUTCHMED (China) Limited to Host Expert Webcast on Savolitinib Phase III Clinical Data
Source: Nasdaq
Healthcare & Biotech
HUTCHMED said it will co-host a virtual webcast with Citigroup Global Markets Asia for analysts and investors on November 5, 2026, at 4:30 pm HKT / 8:30 am GMT / 3:30 am EST. The event will focus on recent Phase III clinical data; the provided article text does not specify the findings.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Artiva halts AlloNK development, cuts 94% of workforce
- Universal Health Services falls 3% on legal settlement concerns
- Midterm elections: How affordability and the economy could impact voters
- adar1 capital management buys $53,691 of NextCure stock
- Zura Bio shares jump on Wedbush buy call ahead of trial data
- Why is Artiva Biotherapeutics stock collapsing today?